Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Abstract LB353: Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors

Nicolas Cuburu, Shiv K. Sethi, Claire E. Bradley, Lukas Bialkowski, Cynthia D. Thompson, Douglas R. Lowy, John T. Schiller

Cancer Res (2024) 84 (7_Supplement): LB353.

https://doi.org/10.1158/1538-7445.AM2024-LB353

Published: 05 April 2024

View articletitled, Abstract LB353: Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors

Journal Articles

Abstract 1730: A novel chimeric virus-like drug conjugate (VDC) for the potential treatment of HPV-positive tumors

Rhonda C. Kines, Anneli Savinainen, Elisabet de los Pinos, John T. Schiller

Cancer Res (2023) 83 (7_Supplement): 1730.

https://doi.org/10.1158/1538-7445.AM2023-1730

Published: 04 April 2023

View articletitled, Abstract 1730: A novel chimeric virus-like drug conjugate (VDC) for the potential treatment of HPV-positive tumors

Journal Articles

Abstract 6295: Belzupacap sarotalocan, an investigational virus-like drug conjugate, preferentially binds cancer cell glycosaminoglycans associated with the epithelial to mesenchymal transition

Nathan R. Fons, Rhonda C. Kines, John T. Schiller

Cancer Res (2023) 83 (7_Supplement): 6295.

https://doi.org/10.1158/1538-7445.AM2023-6295

Published: 04 April 2023

View articletitled, Abstract 6295: Belzupacap sarotalocan, an investigational virus-like drug conjugate, preferentially binds cancer cell glycosaminoglycans associated with the epithelial to mesenchymal transition

Journal Articles

Abstract 5331: Biological assessment of the virus-like drug conjugate AU-011 to specifically target a breadth of human cancer types

Rhonda C. Kines, Nathan R. Fons, Elisabet de los Pinos, John T. Schiller

Cancer Res (2022) 82 (12_Supplement): 5331.

https://doi.org/10.1158/1538-7445.AM2022-5331

Published: 15 June 2022

View articletitled, Abstract 5331: Biological assessment of the virus-like drug conjugate AU-011 to specifically target a breadth of human cancer types

Journal Articles

Abstract 5563: Harnessing pre-existing viral immunity for development of a broadly applicable tumor immunotherapy

Nicolas Cuburu, Lukas Bialkowski, Sergio M. Pontejo, Alexander Bell, Rina Kim, Cynthia D. Thompson, Douglas R. Lowy, John T. Schiller

Cancer Res (2020) 80 (16_Supplement): 5563.

https://doi.org/10.1158/1538-7445.AM2020-5563

Published: 15 August 2020

View articletitled, Abstract 5563: Harnessing pre-existing viral immunity for development of a broadly applicable tumor immunotherapy

Journal Articles

Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure

Daniel C. Beachler, Aimee R. Kreimer, Mark Schiffman, Rolando Herrero, Sholom Wacholder, Ana Cecilia Rodriguez, Douglas R. Lowy, Carolina Porras, John T. Schiller, Silvia Jimenez, Linda Struijk, John Schussler, Allan Hildesheim, Paula Gonzalez, Costa Rica Vaccine Trial Group

Cancer Res (2015) 75 (15_Supplement): 4680.

https://doi.org/10.1158/1538-7445.AM2015-4680

Published: 01 August 2015

View articletitled, Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure

Journal Articles

Abstract 1770: Viral-based nanoparticles: a new therapeutic approach for anticancer therapy

Rhonda Kines, Debaditya Bhattacharya, John R. MacDougall, Diane Milenic, Martin W. Brechbiel, Elisabet de los Pinos, John T. Schiller

Cancer Res (2014) 74 (19_Supplement): 1770.

https://doi.org/10.1158/1538-7445.AM2014-1770

Published: 01 October 2014

View articletitled, Abstract 1770: Viral-based nanoparticles: a new therapeutic approach for anticancer therapy

Journal Articles

Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination

John T. Schiller, Douglas R. Lowy

Cancer Res (2006) 66 (21): 10229–10232.

https://doi.org/10.1158/0008-5472.CAN-06-0630

Published: 01 November 2006

View articletitled, Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination

Journal Articles

Transformation by Human Papillomavirus 16 E6 and E7: Role of the Insulin-like Growth Factor 1 Receptor

Michael A. Steller, Zhiqiang Zou, John T. Schiller, Renato Baserga

Cancer Res (1996) 56 (21): 5087–5091.

Published: 01 November 1996

View articletitled, Transformation by Human Papillomavirus 16 E6 and E7: Role of the Insulin-like Growth Factor 1 Receptor

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract LB353: Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors

Abstract 1730: A novel chimeric virus-like drug conjugate (VDC) for the potential treatment of HPV-positive tumors

Abstract 6295: Belzupacap sarotalocan, an investigational virus-like drug conjugate, preferentially binds cancer cell glycosaminoglycans associated with the epithelial to mesenchymal transition

Abstract 5331: Biological assessment of the virus-like drug conjugate AU-011 to specifically target a breadth of human cancer types

Abstract 5563: Harnessing pre-existing viral immunity for development of a broadly applicable tumor immunotherapy

Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure

Abstract 1770: Viral-based nanoparticles: a new therapeutic approach for anticancer therapy

Prospects for Cervical Cancer Prevention by Human Papillomavirus Vaccination

Transformation by Human Papillomavirus 16 E6 and E7: Role of the Insulin-like Growth Factor 1 Receptor

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only